Search by Drug Name or NDC
NDC 71335-9764-01 Chlordiazepoxide Hydrochloride and Clidinium Bromide 5; 2.5 mg/1; mg/1 Details
Chlordiazepoxide Hydrochloride and Clidinium Bromide 5; 2.5 mg/1; mg/1
Chlordiazepoxide Hydrochloride and Clidinium Bromide is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE.
MedlinePlus Drug Summary
The combination of chlordiazepoxide and clidinium is used along with other medications to treat peptic ulcers, irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea), and enterocolitis (swelling in the intestines). Chlordiazepoxide is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain. Clidinium is in a class of medications called anticholinergics. It helps to decrease stomach spasms and cramps.
Related Packages: 71335-9764-01Last Updated: 05/19/2024
MedLinePlus Full Drug Details: Chlordiazepoxide and Clidinium
Product Information
| NDC | 71335-9764 |
|---|---|
| Product ID | 71335-9764_14333b2e-2e13-424d-819a-b08667725247 |
| Associated GPIs | |
| GCN Sequence Number | 004902 |
| GCN Sequence Number Description | chlordiazepoxide/clidinium Br CAPSULE 5 MG-2.5MG ORAL |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 74801 |
| HICL Sequence Number | 002037 |
| HICL Sequence Number Description | CHLORDIAZEPOXIDE/CLIDINIUM BROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 5; 2.5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
| Labeler Name | Bryant Ranch Prepack |
| Pharmaceutical Class | Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA211421 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71335-9764-01 (71335976401)
| NDC Package Code | 71335-9764-1 |
|---|---|
| Billing NDC | 71335976401 |
| Package | 100 CAPSULE in 1 BOTTLE (71335-9764-1) |
| Marketing Start Date | 2023-08-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |